Copeland Capital Management’s MetLife MET Stock Holding History

Copeland Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	282
2020 Q1	$0	Buy	+1	New	+$44	﹤0.01%	299

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Copeland Capital Management's MET Position: Q2 2020 in Review

Copeland Capital Management sold out of MetLife (MET) in Q2 2020, closing a stake of 1 share.

Copeland Capital Management first reported a position in MET in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 981 funds tracked by Wall St. Rank hold MET as of Q2 2020.

Copeland Capital Management reported no remaining MetLife position as of Q2 2020 after selling out during the quarter.
Copeland Capital Management sold 1 MetLife share in Q2 2020.
Copeland Capital Management first reported a position in MetLife in Q1 2020 and held it in 1 quarter.
Copeland Capital Management's MetLife position peaked at $0 in Q1 2020.
981 funds tracked by Wall St. Rank held MetLife as of Q2 2020.

Based on Copeland Capital Management's 13F filing for Q2 2020, filed 30 Jul 2020.